UPDATE: Pain Therapeutics (PTIE), DURECT (DRRX) Sink in Active Trade
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Notable 52-Week Highs and Lows of the Day 11/01: (RDN) (RTK) (V) High; (WU) (ABMD) (PTIE) Low
November 1, 2012 2:22 PM EDTThis report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.
52-Week High:Radian Group, Inc. (NYSE: RDN) $5.47. Radian Group reported profit of 11 cents per share, which included items. The Company posted profit of $1.37 in the same period last year, which also include cerain items.
Rentech, Inc. (AMEX: RTK) high of... More
C.K. Cooper Downgrades Durect Corp (DRRX) to Hold
November 1, 2012 12:38 PM EDTC.K. Cooper downgraded Durect Corp (NASDAQ: DRRX) from Buy to Hold.
For an analyst ratings summary and ratings history on Durect Corp click here. For more ratings news on Durect Corp click here.
Shares of Durect Corp closed at $1.37 yesterday, with a 52 week range of $0.68-$1.71.... More
C.K. Cooper Downgrades Pain Therapeutics (PTIE) to Hold
November 1, 2012 12:18 PM EDTC.K. Cooper downgraded Pain Therapeutics (NASDAQ: PTIE) from Buy to Hold.
For an analyst ratings summary and ratings history on Pain Therapeutics click here. For more ratings news on Pain Therapeutics click here.
Shares of Pain Therapeutics are down 27 percent.... More

